CTOs on the Move

Reckitt Benckiser

www.rb.com

 
We protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. Our products reach millions of people every day, as we fight to improve global access to the highest quality hygiene, wellness and nourishment. We`re a growing community of 40,000+ diverse, talented entrepreneurs, and the driving force behind some of the world`s most loved and trusted brands. Our portfolio includes household names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Lysol, Dettol, Harpic, Cillit Bang, Finish and Vanish. Hygiene, Health and Nutrition are the focus areas of our business, and the categories under which our brands ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.rb.com
  • 399 Interpace Parkway P.O. Box 225
    Parsippany, NJ USA 07054
  • Phone: 973.404.2600

Executives

Name Title Contact Details
Rama Donepudi
Chief Information Officer (CIO), Global Nutrition at Reckitt Profile
Filippo Catalano
Chief Information and Digitisation Officer Profile
Magdalena Skorupa
Director of Cyber Risk and Compliance Profile

Similar Companies

California MedTech

California MedTech, LLC is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Our Lady of the Valley Retirement Community

Our Lady of the Valley is a non-profit, non-denominational senior living community that provides assisted living, long term nursing, and skilled rehabilitation care. They strive to enhance the quality of life for their senior living residents through p...

Unistrut Corporation a division of Tyco

Unistrut Corporation a division of Tyco is a Wayne, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alnylam

Alnylam is the world`s leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market. We are developing RNAi (RNA interference) as an innovative, entirely new class of medicines to treat rare genetic, cardio metabolic, acute hepatic infectious and central nervous system (CNS) and ocular diseases. Alnylam was founded in 2002 based on a Nobel Prize-winning breakthrough in biology – the discovery of RNAi, and a bold vision that this discovery could be used to silence disease-causing genes upstream of today`s medicines. We are relentless in our pursuit of new treatments because we believe that RNAi therapeutics can be used to treat many diseases for which treatment options do not exist or are inadequate. Overall, we believe that patients shouldn`t have to wait for hope. Alnylam is turning scientific possibility into reality - in 2018, the FDA and European EMA approved of our first product, ONPATTRO (patisiran) which is also the first-ever approved RNAi therapeutic. In 2019, the FDA approved our second product, GIVLAARI (givosiran). Our robust pipeline of investigational medicines includes multiple programs in late-stage and early-stage clinical development. We are a global and diverse company of more than 1,500 people. We pride ourself on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That`s why we`ve been named a Science Magazine Top Employer for two years in a row (`19-`20), a Boston Globe Top Place to Work 5x in a row (`15-`19) and one of Fast Company`s 50 Most Innovative Companies for 2019. We are based in Cambridge, U.S., with offices throughout Europe, Asia and South America.

Heritage At Falmouth

Heritage At Falmouth is a Falmouth, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.